Skip to content

Public FDA record

Z-2542-2021: The Instructions for Use (IFU) for: Gelsoft Plus Bifurcate, Gelsoft Plus Ax-Fem, GelsoftPlus ERS Ax-Fem,

Recall record Z-2542-2021 for Vascutek, Ltd.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2542-2021
Company in FDA record
Vascutek, Ltd.
FDA record creation date
Sep 24, 2021
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The devices contained the IFU for distribution to ROW (rest of world) consignees rather than U.S. consignees.

Source facts

Action
The recalling firm sent emails on 7/8/2021 to the two distributors that contained the Field Safety Notice and the correct IFU to be supplied with products distributed to the United States.
Initiated
2021-07-08
Root cause
Under Investigation by firm
Terminated
2024-08-19
Distribution
Distribution was made to PR and Guam.
Recall number
Z-2542-2021
Recall status
Terminated
CDRH record ID
188272
FDA record created
2021-09-24
Recall event number
88278

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗